Pricing Log in Create free account

Coya Therapeutics, Inc. (COYA) vs Champions Oncology, Inc. (CSBR)

Coya Therapeutics, Inc. and Champions Oncology, Inc. are both Biotechnology companies. Coya Therapeutics, Inc. and Champions Oncology, Inc. are of similar size ($66.3M and $65.9M). Coya Therapeutics, Inc. grew revenue faster over the last twelve months: 108.4% against 6.65%. Champions Oncology, Inc. has the higher net margin (−1.87% vs −270.2%) and the higher return on invested capital (−626.2% vs −15,230.9%). Across the 16 metrics below, Champions Oncology, Inc. leads on 11 and Coya Therapeutics, Inc. on 5.

Valuation

Metric COYA CSBR Biotechnology median
P/E n/m n/m 10.60
P/S 8.69 1.10 9.40
P/B 1.61 14.96 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 200.80 0.66
EV/Sales 4.92 1.03 9.02
Earnings yield (36.03%) (1.67%) (32.88%)
Free cash flow yield (25.51%) (9.16%) (23.13%)

Profitability

Metric COYA CSBR Biotechnology median
Gross margin 100.00% 49.82% 68.51%
Operating margin (288.70%) (1.68%) 0.00%
Net margin (270.22%) (1.87%) 0.00%
Free cash flow margin (221.64%) (10.08%) 0.00%
Return on equity (60.54%) (28.38%) (51.96%)
Return on assets (53.66%) (3.56%) (46.06%)
Return on invested capital (15,230.92%) (626.23%) 0.00%

Growth

Metric COYA CSBR Biotechnology median
Revenue growth (TTM) 108.35% 6.65% 6.76%
EPS growth (last fiscal year) (29.59%) (124.24%) 29.88%
Revenue growth, 5-year CAGR — 7.68% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric COYA CSBR Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 13.40 1.03 4.97
Net debt to EBITDA 2.08 (20.56) 1.01

Dividend

Metric COYA CSBR Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric COYA CSBR Biotechnology median
Market cap 65.92m 66.26m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack